Connection

John Lazarchick to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications John Lazarchick has written about Imatinib Mesylate.
John Lazarchick
Connection Strength
0.069
Imatinib Mesylate
  1. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leuk Lymphoma. 2005 Nov; 46(11):1667-70.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.